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Antioxidant enzymeMitochondrial diseases originate from mutations in mitochondrial or nuclear genes encoding for
mitochondrial proteome. Neurogenic muscle weakness, ataxia and retinitis pigmentosa (NARP) syndrome
is associated with the T8993G transversion in ATP6 gene which results in substitution at the very
conservative site in the subunit 6 of mitochondrial ATP synthase. Defects in the mitochondrial respiratory
chain and the ATPase are considered to be accompanied by changes in the generation of reactive oxygen
species (ROS). This study aimed to elucidate effects of selenium on ROS and antioxidant system of NARP
cybrid cells with 98% of T8993G mutation load. We found that selenium decreased ROS generation and
increased the level and activity of antioxidant enzymes such as glutathione peroxidase (GPx) and
thioredoxin reductase (TrxR). Therefore, we propose selenium to be a promising therapeutic agent not only
in the case of NARP syndrome but also other diseases associated with mitochondrial dysfunctions and
oxidative stress.ted at Fax: +48 22 8225342.
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Mitochondria accomplish several vital functions in the cell and,
therefore, their malfunction is usually associated with numerous
multisystem syndromes [1], neurodegenerative diseases [2], cancer
[3] and ageing [4]. However, it is often a matter of debate whether
mitochondrial dysfunctions are their causative factors or, rather, their
results. It is now generally assumed that the so-called “mitochondrial
diseases” originate from mutations in mitochondrial or nuclear genes
encoding for mitochondrial proteins. Defects in the mitochondrial
respiratory chain and the ATP-synthesizing machinery are often
accompanied by increased generation of oxygen free radicals, mainly
the superoxide anion radical O2•−, and/or deﬁciency of antioxidant
systems. As a result, many mitochondrial and neurodegenerative
diseases as well as malignant transformations and ageing are
accompanied by oxidative stress [5–7].
The present investigation is aimed to elucidate the possibility that
a deﬁciency in the antioxidant defence system may be one of the
causative factors of the NARP syndrome. Neurogenic muscle weak-
ness, ataxia and retinitis pigmentosa (NARP) is associated with the
T8993G transversion in ATP6 gene, which results in substitution of
Leu-156 with Arg in the subunit 6 of mitochondrial ATP synthase
complex [8]. When the degree of penetration of the mutation exceeds90%, more severe clinical symptoms known as maternally inherited
Leigh syndrome (MILS) occur [9]. There is no precise data concerning
epidemiological impact of T8993G mtDNA mutation. However, there
is a general agreement that mitochondrial diseases are more frequent
than previously thought [10] and between them the NARP/MILS
syndrome is one of the most common [9].
Because the present knowledge on the efﬁciency of antioxidant
response in the NARP syndrome is not sufﬁcient, we investigated an
array of antioxidant enzymes and ROS level in human osteosarcoma
cells harboring mtDNA T8993G mutation in ATP6 gene with 98% of
heteroplasmy. This mutation leads to defective ATP synthase and
reduction of ATP production in patient-derived human ﬁbroblasts
harboring this mutation at levels above 90% [11] due to inhibition of
proton transport by ATP synthase [11] or inefﬁcient coupling of
proton transport through Fo to ATP synthesis on subunit F1 [12] as
well as impairment of the holoenzyme assembly and stability [13].
Severity of symptoms observed in NARP (T8993G) patients correlates
positively with the percentage of mutated mtDNA copies per cell [6].
Our interest was focused on main antioxidant enzymes, like
superoxide dismutases (SODs; EC 1.15.1.1), glutathione peroxidase
(GPx; EC 1.11.1.9), catalase (CAT; EC 1.11.1.6), thioredoxin reductases
(TrxRs; EC 1.6.4.5) and methionine sulphoxide reductases (Msrs; EC
1.8.4.5). To complete our search for the antioxidant defence system of
NARP cybrid cells, we extended our investigation over the nuclear
respiratory factor 2 (Nrf2), the major regulator of ROS-induced
antioxidant response [14,15]. As selenium plays a pivotal role in the
cellular antioxidant defence system, we also investigated effects of
supplementation of this element on ROS level in NARP cells.
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osteosarcoma cells harboring mtDNA mutation associated with the
NARP syndrome is higher and the expression of some antioxidant
enzymes is lower compared to wild type cells. Selenium supplemen-
tation caused a decrease in ROS level and an increase in the activity
of antioxidant selenoproteins such as glutathione peroxidase and
thioredoxin reductase.
2. Materials and methods
2.1. Chemicals and antibodies
MitoSOX Red, dihydroethidium (DHE) and 5-(and-6)-chloro-
methyl-2′7′-dichlorodihydroﬂuorescein diacetate acetyl ester (CM-
H2DCFDA) were from Invitrogen (Eugene, OR) and 5-bis{[2-
(dimethylamino) ethyl]amino}-4,8-dihydroxyanthracene-9,10-dione
(DRAQ5TM) was from Biostatus Limited (Shepshed, United Kingdom).
TrxR and GPx activity kits were purchased from Cayman Chemical
(Ann Arbor, MI) and Bio-Rad Protein Assay was from Bio-Rad
Laboratories (Munich, Geremany). Trypsine and Tween were from
Sigma Aldrich (St. Louis, MO). Dithiothreitol (DTT) was purchased
from Serva Feinbiochemica (Heidelberg, Germany). All other chemi-
cals were of analytical grade.
Primary antibodies directed against thioredoxin reductase 2
(TrxR2) (1:2000), thioredoxin 2 (Trx2) (1:1000), thioredoxin 1
(Trx1) (1:400) and methionine sulphoxide reductase A (MsrA)
(1:2000) were from AbCam (Cambridge, UK); those directed against,
CAT (1: 2500) and β-actin-peroxidase (1:50,000) were from Sigma
Aldrich (St. Louis, MO). Anti-GPx (1:100) antibody was purchased
from Medical & Biological Laboratories Co. (Woburn, MA) and anti-
thioredoxin reductase 1 (TrxR1) (1:500) antibody was from Upstate
(Lake Placid, NY). Anti-copper/zinc superoxide dysmutase (Cu/
ZnSOD) (1:300) antibody and anti-manganese superoxide dysmutase
(MnSOD) (1:500) antibody were obtained from BD Pharmingen
(San Diego, CA), whereas anti-Nrf2 (1:1000) and anti-Nrf2 phos-
phorylated at serine 40 (pNrf2 (pS40)) (1:10,000) were from
Epitomics (Burlingame, CA). All secondary antibodies were from
Santa Cruz Biotechnology (Santa Cruz, CA).
2.2. Cell lines and culture conditions
Parental human osteosarcoma cell line 143B, cybrid cell line
derived from NARP skin ﬁbroblasts 143B/206 with 98% penetration of
the mtDNA T8993G mutation in ATP6 gene and Rho0 cell line lacking
mitochondrial DNA [16] were kindly provided by Dr. M. Tanaka of the
Department of Gene Therapy, Gifu International Institute of Biotech-
nology, Japan. The cells were cultured at 37 °C in a humidiﬁed
atmosphere containing 5% CO2 in high glucose Dulbecco's modiﬁed
Eagle's medium (DMEM) supplemented with 10% heat-inactivated
foetal bovine serum (FBS) (Gibco, Grand Island, NY), uridine 50 µg/ml
and antibiotics: 100 U/ml penicillin, 100 µg/ml streptomycin (Sigma
Aldrich, St. Louis MO) . Sodium selenite (Na2SeO3) 70 nM (Sigma
Aldrich, St. Louis, MO) was added where indicated (basic concentra-
tion of selenium in DMEM before selenium supplementation varies
between 7 and 40 nM, due to FBS addition). All experiments were
performed with cells between the 3rd and the 6th passages.
2.3. Whole cell extracts
The cells were harvested with trypsine, washed with ice-cold PBS,
sedimented by centrifugation and resuspended in the lysis buffer
at 4 °C (50 mM Tris–HCl, 150 mM NaCl, 1% Triton X-100, 1% Nonidet
P-40, 5 mM EDTA, protease inhibitors and phosphatase inhibitors:
1 μg/ml aprotynin, 1 mM PMSF, 1 mM sodium orthovanadate and
10 mM NaF). After 20 min, cell lysates were homogenised and
centrifuged at 8600×g for 20 min at 4 °C. The supernatants werecollected and the protein concentration was determined according to
Bradford [17]. The samples were supplemented with SDS sample
buffer (0.5 M Tris–HCl, 2.3% SDS, 5% mercaptoethanol (v/v), 12.5%
glycerol (v/v); pH 6.8) and subjected to further analysis.
2.4. Immunoblotting
Lysates containing equal amounts of protein were separated by
SDS-PAGE, transferred to nitrocellulose membrane and blocked with
5% non-fat dry milk/TBS-0.05% Tween solution. The washed
blots were incubated with primary antibodies at concentrations
corresponding to manufacturers' instructions. Upon washing in TBS-
0.05% Tween, the blots were incubated with secondary antibodies
labelled with horseradish peroxidase. The signal was detected with
chemiluminescence detection kit (Bio-Rad Laboratories, Munich,
Germany).
2.5. Measurement of TrxR and GPx activities
The cells were washedwith ice-cold PBS, scraped and resuspended
in the same medium. Upon centrifugation at 86×g at 4 °C for 10 min,
supernatants were decanted and pellets were freezed to −80 °C for
30 min. Subsequently, the pellets were resuspended at 0 °C in 50 mM
Tris–HCl and 1 mM EDTA (pH 7.45) for TrxR or in 50 mM Tris–HCl,
5 mM EDTA and 1 mM DTT (pH 7.5) for GPx activity. The lysates were
homogenised by three freezing/thawing cycles and subsequently
centrifuged at 17,000×g at 4 °C for 20 min [18]. Protein concentration
was determined according to Bradford [17]. TrxR and GPx activities
were measured with thioredoxin reductase and glutathione perox-
iadse assay kits according to manufacturers' instructions using
microplate reader (Inﬁnite M200, Tecan, Austria).
2.6. Quantiﬁcation of ROS
The level of ROS such as the superoxide anion radical and
hydrogen peroxide in adherent cells was measured without their
prior detachment in laser scanning cytometer iCys (CompuCyte Inc.,
Cambridge, MA).
Cytosolic and mitochondrial levels of O2•− were estimated using
DHE and its mitochondria-targeted derivative MitoSOX Red [19,20].
Intracellular formation of H2O2 was measured with CM-H2DCFDA
[21,22].
Adherent cells were prepared and measured on a multi-well plate.
Live cells were rinsed with PBS and stained with the appropriate
ﬂuorescent dye. In some experiments, cell nuclei were counterstained
with 10 µMDRAQ5™ for 10 min at room temperature for cell triggering
and the excitation and emission wavelengths of 488 nm and 681 nm,
respectively, were measured. A minimal area of 30 µm2 was deﬁned,
and 25 pixelswere added to cover the entire cell. To collect datawithout
staining of the nuclei, phantom counters were generated. Data were
acquired and analysed with software iCys version 2.5.
2.7. Statistical and densitometric analysis
The data represent means±SD for at least three independent
experiments. Statistical signiﬁcance was assessed with Student's
paired t-test and only P values of less than 0.05 were considered
signiﬁcant. ImageJ densitometry software was used for gel band
quantitative densitometric analysis.
3. Results
3.1. ROS level
As shown in Fig. 1.A.I and B.I, the level of superoxide anion radical
O2•− was higher in NARP cells than in wild type cells in both the
Fig. 1. (I), The level of ROS (A–C). The values obtained for NARP and Rho0 cells were compared with WT which was ascribed an arbitrary value of 100%. (II), Changes in ROS upon
selenium supply (10–14 days); corresponding cell lines not supplemented with selenium were used as controls and ascribed the value of 100%. The values on the graphs represent
means±SD from at least 3 independent experiments. The symbols * denote values signiﬁcantly different from controls: Pb0.05⁎, Pb0.01⁎⁎, Pb0.001⁎⁎⁎.
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28%, Pb0.05, n=3). In Rho0 cells, the cytosolic level of the superoxide
was not elevated (Fig. 1.A.I), whereas in mitochondria it was found
lower (by 72±43% (Pb0.05, n=3) when compared to wild type cells
(Fig. 1.B.I). Selenium supplementation signiﬁcantly lowered the
superoxide anion level only in mitochondria of NARP cells (by 29±
22%, Pb0.05, n=3), Fig. 1.B.II).
Hydrogen peroxide (H2O2) level was found higher in NARP cells
than in wild type cells (by 24±10%, Pb0.001, n=6) but was not
changed in Rho0 cells (Fig. 1.C.I). Selenium supplementation
decreased H2O2 level by 17±10% (Pb0.001, n=6), 17±13%
(Pb0.001, n=6) and 12±8% (Pb0.001, n=6) in wild type, NARP
and Rho0 cell populations, respectively (Fig. 1.C.II).
3.2. ROS scavenging enzymes
The protein level of mitochondrial superoxide dismutase, MnSOD,
was strongly decreased in both NARP and Rho0 cells (by 83±1%,
Pb0.001, n=3 and 87±4%, Pb0.001, n=3, respectively) compared
to wild type cells (Fig. 2.A.I). The opposite situation was observed in
the case of the cytosolic superoxide dismutase, Cu/ZnSOD. This
enzyme was higher in both NARP (by 40±23%, Pb0.05, n=3) and
Rho0 (by 65±29%, Pb0.01, n=3) cells (Fig. 2.B.I).
The level of CAT in NARP cells was lower by 21±10% (Pb0.01,
n=4) and in Rho0 cells by 37±20% (Pb0.01, n=4) than in the wild
type (Fig. 2.C.I). Neither SOD enzymes nor CAT level was affected by
selenium supplementation (Fig. 2.A.II, B.II and C.II).
The protein level of GPx in NARP cells was not changed
signiﬁcantly but was higher by 168±74% (Pb0.01, n=5) in Rho0
cells (Fig. 2.D.I). Selenium supplementation increased the protein
level of this enzyme in all three kinds of cells, by 86±33% (Pb0.01,n=4) inwild type cells, by 73±29% (Pb0.01, n=4) in NARP cells and
by 47±15% (Pb0.001, n=4) in Rho0 cells (Fig. 2.D.II). Changes in GPx
determined by its activity revealed statistically signiﬁcant increase in
both NARP (by 78±27%, Pb0.001, n=4) and Rho0 cells (by 47±37%,
Pb0.05, n=4) (Fig. 2.E.I). Upon selenium supplementation, activities
of this enzyme increased by 219±42% (Pb0.001, n=4), 62±8%
(Pb0.001, n=4) and 143±28% (Pb0.001, n=4) in wild type, NARP
and Rho0 cells, respectively (Fig. 2.E.II).3.3. Enzymes repairing oxidative damage
Thioredoxin (Trx; EC 1.8.4.8), thioredoxin reductase and methio-
nine sulphoxide reductase (Msr) can be regarded as enzymes that can
repair oxidative damage.
It appeared that the protein level of the mitochondrial isoform
of thioredoxin reductase (TrxR2) was not altered in any of the
investigated cell lines (Fig. 3.B.I) whereas the level of its cytosolic/
nuclear counterpart (TrxR1) was higher by 50±39% (Pb0.05, n=3)
only in Rho0 cells (Fig. 3.A.I). After selenium treatment, the level of
TrxR2 was not changed (Fig. 3.B.II), but the level of the TrxR1 was
higher in wild type cells by 28±16% (Pb0.01, n=5) (Fig. 3.A.II). We
sometimes observed an increase in TrxR1 level in NARP cells, but this
was not a repetitive event and, therefore, was not found statistically
signiﬁcant.
When determined as the enzyme activity, TrxR was found
signiﬁcantly lower (by 51±24%, Pb0.01, n=4) only in Rho0 cells
(Fig. 3.C.I) compared to wild type. Addition of selenium increased
TrxR activity by 50±29% (Pb0.01, n=4) and 43±40%, (Pb0.05,
n=4) in wild type and NARP cells, respectively, but had no effect on
Rho0 cells (Fig. 3.C.II).
Fig. 2. (I), The level of ROS scavenging enzymes (A–D) and GPx activity (E). The values obtained for NARP and Rho0 cells for particular enzymes were compared with WT control
which was ascribed an arbitrary value of 100%. (II), Changes in the level of antioxidant enzymes upon selenium supply and GPx activity; corresponding cell lines not supplemented
with selenium (10–14 days) were used as controls and ascribed the value of 100%. The values on the graphs represent means±SEM of at least 3 independent experiments.
Representative Western Blot images with ß-actin used as the loading control are shown. The symbols * denote values signiﬁcantly different from controls: Pb0.05⁎, Pb0.01⁎⁎,
Pb0.001⁎⁎⁎.
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both NARP and Rho0 cells by 42±23% (Pb0.01, n=4) and 39±25%
(Pb0.01, n=4) (Fig. 3.D.I), whereas the level of the mitochondrial
isoform (Trx2) was lower in these two cell lines by 44±22% (Pb0.05,
n=3) and 57±19% (Pb0.01, n=3), respectively (Fig. 3.E.I). Selenium
supplementation did not affect the level of Trx in either cell line
(Fig. 3.D.II and E.II).
The protein level of MsrAwas found higher in NARP and Rho0 cells
by 30±16% (Pb0.02, n=4) and 43±12% (Pb0.001, n=4), respec-tively, compared to the wild type. Upon selenium supplementation,
no signiﬁcant change in theMsrA level was observed in either cell line
(Fig. 3.F.I and F.II).
3.4. Nuclear respiratory factor 2 (Nrf2)
The level of Nrf2 was lower by 43±20% (Pb0.001, n=4) and 61±
25% (Pb0.01, n=4) inNARP andRho0 cells, respectively (Fig. 4.A.I). The
level of Nrf2 phosphorylated at serine S40 was also lower in NARP cells
Fig. 3. (I), The level of enzymes involved in repair of protein oxidative damage (A, B, D, E, F) and activity of thioredoxin reductase (C). (II), Changes in the level of antioxidant
enzymes and the total activity of TrxR after selenium supplementation. Representative Western Blot images are shown with ß-actin used as the loading control. The values on the
graphs represent means±SD of at least 3 independent experiments and the symbols * denote values signiﬁcantly different from controls: Pb0.05⁎, Pb0.01⁎⁎, Pb0.001⁎⁎⁎.
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(Pb0.01, n=3) (Fig. 4.B.I). To assess the induction ofNrf2,we compared
the level of Nrf2 phosphorylated at serine 40 (pNrf2 (S40)) with thetotal level of Nrf2 in these cells and found that this transcription factor
was induced in NARP and Rho0 cells in comparison to wild type cells
(Table 1).
Fig. 4. (I), The level of Nrf2 and pNrf2 (S40) and their changes after selenium supply (II). Representative Western Blot image of Nrf2 and pNrf2 (S40) is shown. The membrane was
ﬁrst blotted against total Nrf2, then stripped and blotted against pNrf2 (S40) and ß-actin as the loading control. The values on the graphs represent means±SD of at least 3
independent experiments and the symbols * denote values signiﬁcantly different from controls: Pb0.05⁎, Pb0.01⁎⁎, Pb0.001⁎⁎⁎.
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188±116% (Pb0.05, n=4) and a decrease in Rho0 cells by 44±40%
(Pb0.05, n=4) (Fig. 4.A.II). We also observed an increase of Nrf2
level upon selenium treatment in NARP cell line but found it not
to be statistically signiﬁcant, probably due to limited sensitivity of
Western Blotting technique. Selenium supplementation did not
affect the level of pNrf2 (S40) (Fig. 4.B.II). However, comparison
of pNrf2 (S40) with the total level of Nrf2 upon selenium supply
revealed that selenium stimulated induction of this transcription
factor only in Rho0 cells (Table 1).
4. Discussion
Transmitochondrial cybrids have been widely used in a mitochon-
drial research to elucidate a phenotype of cells harboring speciﬁc
mtDNA mutations. Cybrids with patient-derived mitochondria were
obtained by fusion of enucleated NARP patient cells with Rho0 cells
that lack mtDNA and were obtained from a given human cell line [16]
(referred to as a “wild type, WT”). In this way, any phenotype
differences observed among cybrids, WT and Rho0 cells result fromTable 1
Nrf2 activity. Densitometric data was used to assess Nrf2 activity via its phosphory-
lation at serine S40 by estimation of pNrf2 (S40)/Nrf2 ratio. The similar ratio was
obtained for cells subjected to Se supplementation (Se). The symbol * indicates the
induction of Nrf2 activity without selenium supplementation whereas # indicates
increased induction upon selenium supply.
Ratio WT NARP Rho0
pNrf2 (S40)/Nrf2 1 1.3±0.17⁎ 3.1±0.17⁎#
pNrf2 (S40)-Se/Nrf2-Se 1±1.79 2.25±1.15 4.67±0.72#alterations in their mtDNA as they have the same nuclear genome. In
this study, we provide an overview of antioxidant defence systems
and ROS generation in NARP cybrid cells in comparisonwith wild type
and Rho0 cell lines.
We have previously shown that organisation of the mitochondrial
network, the cytoskeleton and calcium homeostasis in NARP cybrid
cells with 98%mutation load differs from that inwild type cells [23]. In
the present study, we demonstrate differences in the production of
reactive oxygen species, O2•− and H2O2, and the efﬁciency of the
antioxidant systems. We also show that selenium, a natural diet
micronutrient, can act towards reversal of these effects and, thus, may
be considered as a promising therapeutic agent in the case of NARP.
Overproduction of ROS was shown to play an important role in the
pathogenesis of NARP syndrome and various antioxidants have been
successfully used as its potent therapeutic agents [24,25]. Taking
superoxide dismutase activity as an index for superoxide production
[25] cannot always reﬂect the real level of superoxide generation.
Therefore, we undertook a detailed investigation of cytosolic and
mitochondrial O2•− levels and found them higher in NARP than in wild
type cells (Fig. 1.A.I and B.I). We have also observed that changes in
the protein level of O2•−-scavenging enzymes do not fully reﬂect the
changes in the level of O2•− in either NARP cybrid nor Rho0 cells
(Fig. 1.A.I, B.I, A.I and B.I).
The differentiation between cytosolic and mitochondrial O2•−
generation also allowed us to determine that selenium supplemen-
tation lowered the mitochondrial but not the cytosolic level of O2•− in
NARP cybrids (Fig. 1.A.II and B.II). However, it lowered the level of
H2O2 in all three cell lines (Fig. 1.C.II). Such effect of selenium on the
level of H2O2 encouraged us to pursue our investigation towards
H2O2-scavenging enzymes. We found that selenium had a similar
effect on the level and activity of glutathione peroxidase (GPx) (Fig. 2.
D.II and E.II), which is a selenoprotein with selenocysteine in its active
site. This suggests that GPx is the main H2O2-scavenging enzyme in all
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lower in both NARP and Rho0 cells and is not affected by selenium
(Fig. 2.C.I and C.II).
Oxidative modiﬁcation of proteins can result in the impairment or,
even, loss of their functions. There has been no data concerning
antioxidant systems that repair such protein modiﬁcations in cells with
mitochondrial malfunction. To address this issue, we investigated
thioredoxin reductase (TrxR) and methionine sulphoxide reductase
(Msr) systems that reduce protein disulphide bonds and protein
methionine sulphoxides, respectively, and are vital for survival of cells
and organisms [26–30]. Although the activity of TrxR in NARP cybrid
cellswas increasedonly upon seleniumsupplementation (Fig. 3.C.II),we
found that the level of mitochondrial isoform of thioredoxin was
lowered signiﬁcantly in NARP cybrids (Fig. 3.E.I), compared with wild
type cells. According to [31], deﬁciency of Trx2 results in an increased
mitochondrial generation ofH2O2.We conclude that lower level of Trx2,
in addition to the decreased level ofMnSOD, contributes to elevatedROS
level observed in NARP cells and renders themmore prone to oxidative
damage. Increased ROS productionwas also associatedwith silencing of
methionine sulphoxide reductase A (MsrA) gene [32]. Therefore, an
increase of MsrA protein level observed in NARP cells (Fig. 3.F.I)
provides a better protection against oxidative stress.
In cells under oxidative stress, expression of multiple genes
encoding for antioxidant proteins is regulated by Nrf2. Dassa et al.
[33] showed previously that Nrf2 is activated and accumulates in
nuclei of human skin ﬁbroblasts with NARP mutation. We also
observed that the activity of this transcription factor was signiﬁcantly
higher in both NARP and Rho0 cells (Table 1). Although an increase in
the activity of Nrf2 in NARP cells could be explained by elevated ROS
level, we showed for the ﬁrst time that it was even more increased in
Rho0 cells that do not overproduce either O2•− or H2O2 (Fig. 1.A.I, B.I
and C.I). Moreover, selenium that lowered the level of H2O2 in Rho0
cells (Fig. 1.C.II) increased Nrf2 activity even further in this cell line
(Table 1). This may suggest that some other mechanisms than solely
ROS regulate the activity of this transcription factor and, thus, the
cellular response to changes in the functional state of mitochondria
[34].
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